B3HM细胞免疫小鼠脾细胞scFv噬菌体展示文库的构建及表达

目的: 利用噬菌体展示技术构建B3HM细胞免疫小鼠的脾细胞表达scFv文库。方法: 用人骨髓细胞系B3HM细胞免疫小鼠,取其脾细胞采用RT-PCR方法扩增VH 和Vk基因并克隆入噬菌体展示表达载体,构建scFv文库,测定文库的库容量,BstNI酶切单克隆分析文库的多样性,对文库进行富集检测,鉴定单克隆噬菌体与B3HM细胞结合反应。结果:文库的库容为5×106cfu,单克隆的BstNI酶切图谱显示多样性,单克隆噬菌体抗体与B3HM细胞呈阳性反应。结论:噬菌体展示文库的成功构建为寻找新的致白血病相关基因,阐明白血病发病机理奠定了基础。     

抗松材线虫纤维素酶单链抗体库的构建及筛选

构建鼠源性松材线虫纤维素酶（Bursaphelenchus xylophilus cellulase, BXC）的噬菌体单链抗体库,从中筛选特异性BXC的单链抗体。以BXC为抗原免疫BALB/C小鼠,从脾脏提取总RNA,用RT-PCR技术扩增小鼠抗体重链（V_H）和轻链(V_L)可变区基因。经重叠PCR(SOE-PCR)在体外将V_H和V_L连接成单链抗体(scFv)基因,并克隆到噬菌粒载体pCANTAB5E中,电转化至大肠杆菌TG1,经辅助噬菌体超感染,成功构建了库容为5×10⁴的Anti-BXC单链抗体库,并从该抗体库中初步筛选到了特异性识别BXC的噬菌体单链抗体scFv。将表面展示单链抗体的单克隆噬菌体转化大肠杆菌HB2151进行可溶性表达,SDS-PAGE及Western blot分析结果显示,可溶性scFv获得表达,且与BXC具有结合活性,为松材线虫的检验检疫以及病理学研究奠定了基础。     

鼠源E型肉毒毒素免疫噬菌体单链抗体库的构建及筛选

目的:构建鼠源E型肉毒毒素(BoNT/E)免疫噬菌体单链抗体库,筛选BoNT/E特异性抗体。方法:从E型肉毒类毒素免疫小鼠的脾细胞中提取总RNA,反转录成cDNA,分别扩增出小鼠重链可变区基因和轻链可变区基因;通过重叠延伸PCR将重链可变区基因和轻链可变区基因组装成scFv基因,重组于噬粒pS100中,电转化大肠杆菌TG_1,合并所有克隆成初级库;随机挑取克隆进行核苷酸序列测定,对初级库序列多样性进行分析;在辅助噬菌体M_(13)K_(07)的拯救下,构建成scFv噬菌体抗体库;用纯化的BoNT/E对鼠源BoNT/E免疫噬菌体单链抗体库进行3轮富集筛选,制备单克隆的噬菌体抗体颗粒进行酶联免疫吸附试验,阳性克隆进行核苷酸序列测定。结果:鼠源BoNT/E免疫噬菌体单链抗体库的库容为7.09×10~7,随机挑取的20个克隆序列各不相同,序列正确率为85%,基本覆盖了IgHV、IgKV、IgLV的优势家族;纯化的BoNT/E作为抗原通过3轮筛选,噬菌体抗体富集了66倍,第3轮筛选后随机挑取90个克隆制备噬菌体抗体颗粒,酶联免疫吸附试验分析有88个呈现阳性反应,序列比对得到了24个不同序列的BoNT/E特异性抗体。结论:构建了库容量达7.09×10~7的鼠源BoNT/E免疫噬菌体单链抗体库,筛选得到了24个不同序列的BoNT/E特异性抗体。     

人源抗狂犬病毒糖蛋白Ⅲ号表位链置换基因工程抗体研究

为获得针对狂犬病毒糖蛋白Ⅲ号表位的人源单抗,本研究采用噬菌体展示平台,对一株狂犬病毒糖蛋白Ⅲ号抗原表位的人源单抗CR4098采用链置换法进行改造。以CR4098单链抗体为骨架,从狂犬疫苗接种者外周血分离淋巴细胞,提核酸逆转录,PCR扩增抗体轻链可变区基因,替换CR4098的轻链基因,构建轻链置换文库。经纯化狂犬病毒aG株富集筛选,以上述筛选出的轻链阳性克隆为骨架,构建重链置换抗体库,富集筛选后通过ELISA和IFA鉴定阳性抗体克隆并进行序列测定。利用IgG表达载体VH/VK双质粒系统瞬时转染293T细胞实现IgG抗体的分泌型表达,通过亲和力测定和中和试验鉴定IgG抗体功能。结果显示,通过轻链置换,我们获得14株抗狂犬病毒scFv抗体,通过ELISA、IFA、亲和力测定及中和试验确定人源抗体RV3A5特异性结合狂犬病毒糖蛋白,对狂犬病毒CVS株和aG株均具有良好的中和活性,亲和力达到2.8×10-9 M。通过竞争ELISA对抗体结合表位进行鉴定,结果表明RV3A5特异性识别糖蛋白Ⅲ号抗原表位。通过链置换法成功获得1株全新的针对狂犬病毒糖蛋白Ⅲ号表位的高亲和力人源中和抗体,为狂犬病毒抗体制剂鸡尾酒治疗奠定了基础。     

抗整合素β3胞外区噬菌体抗体库的构建及筛选

用RT-PCR的方法从人胶质瘤BT-325细胞中扩增人整合素β3胞外区,并克隆到载体pET-24a中构建表达载体.表达的人整合素β3胞外区经变性、复性和纯化后免疫BALB/c小鼠,提取脾脏总RNA,用RT-PCR技术扩增小鼠抗体重链(VH)和轻链(VL)可变区基因,经重叠PCR(SOE-PCR)将VH和VL连接成单链抗体(scFv)基因,并克隆到噬菌粒载体pCANTAB5E中,电转化至大肠杆菌TGl,经辅助噬菌体M13KO7超感染,构建噬菌体单链抗体库.通过淘选从该抗体库中筛选特异性识别人整合素β3胞外区的噬菌体单链抗体.结果表明,成功构建了库容为2.6×106的抗人整合素β3胞外区的单链抗体库,初步筛选到了与人整合素β3胞外区特异性结合的单链抗体.     

噬菌体抗体库的构建及抗乳腺癌细胞单链抗体的筛选

构建抗人乳腺癌细胞MCF 7的噬菌体单链抗体库 ,从中筛选MCF 7细胞特异性单链抗体。用MCF-7细胞免疫BALB C小鼠 ,取脾脏 ,提取总RNA ,用RT-PCR技术扩增小鼠抗体重链 (V_H)和轻链 (V_L)可变区基因 ,经重叠PCR(SOE-PCR) ,在体外将V_H和V_{L连接成单链抗体 (scFv)基因 ,并克隆到噬菌粒载体pCANTAB5E中 ,电转化至大肠杆菌TG1,经辅助噬菌体超感染 ,构建噬菌体单链抗体库。从该抗体库中筛选特异性识别MCF-7细胞的噬菌体单链抗体 ,将表面展示单链抗体的单克隆噬菌体转化大肠杆菌TOP10进行可溶性表达。成功地构建了库容为12×10⁶ 的抗MCF-7乳腺癌细胞的单链抗体库 ,初步筛选到了与MCF 7细胞特异性结合的scFv,Westernblot检测表明 ,在大肠杆菌TOP10中实现了单链抗体可溶性表达}     

日本血吸虫未成熟卯单链抗体库的构建、筛选及初步应用

运用噬菌体展示技术构建日本血吸虫未成熟虫卵可溶性抗原（SIEA）单链抗体（scFv）表达文库,以天然分子候选疫苗SIEA26～28ku为靶抗原筛选SIEA单链抗体库,获得特异性单链抗体．并将该scFv基因亚克隆至原核高效表达载体PET32a,诱导SIEA26-28ku特异性scFv大量表达．随后以此为探针筛选日本血吸虫尾蚴cDNA文库,以期获得SIEA2628ku天然分子候选疫苗相关的编码基因．结果显示,所获得的SIEA26-28ku特异性scFv,表达量高,采用该探针初步筛选出相关基因核糖体蛋白S4．SIEA26-28ku特异性scFv的获得,为进一步筛选、分析鉴定抗日本血吸虫病天然分子候选疫苗SIEA26-28ku的编码基因奠定了基础．     

核糖体展示口蹄疫单链抗体库的构建

目的:构建库容量大、多样性好的核糖体展示口蹄疫单链抗体(scFv)库。方法: 分离口蹄疫病毒免疫的兔脾细胞,提取总RNA,用RT-PCR扩增兔抗体的重链可变区(VH)基因和轻链可变区(VL)基因,同时扩增作为间隔区的兔抗体Ck基因;采用重叠延伸PCR (简称SOE-PCR)技术连接VH-VL基因,同时引入T7启动子和核糖体结合位点序列,体外构建核糖体展示scFv库模板,连接pMD18-T载体转化E.coli DH5α大肠杆菌,挑取阳性克隆测序以鉴定scFv组装。结果:成功构建了库容量达8.21×10¹³的兔源口蹄疫核糖体展示scFv库。结论: 构建的大容量兔源性口蹄疫核糖体展示抗体库可以成为进一步筛选特异性口蹄疫单链抗体的实验平台,为开发诊断性口蹄疫单链抗体奠定了很好的实验基础。     

抗TNF-α单链抗体噬菌体展示文库的建立和鉴定

应用噬菌体展示技术构建抗肿瘤坏死因子α(tumornecrosis factor α,TNF-α)单链抗体(single chain Fv,scFv)文库,从中筛选抗TNF-αscFv并进行鉴定.利用重组人TNF-α(rhTNF-α)免疫小鼠,分别扩增小鼠VH和VL基因,经重叠延伸反应将VH和VL基因拼接成scFv基因,以SfiⅠ/NotⅠ位点定向插入pCANTAB 5E噬菌粒载体,转化E.coli TG1,构建了库容为4.6×108的抗TNF-α单链抗体库.对抗体库进行3轮富集筛选后,ELISA检测阳性克隆的抗原特异性,取1株阳性克隆进行测序分析.结果表明,抗TNF-αscFv基因序列长774bp,编码258个氨基酸.将此阳性克隆转化E.coliHB2151,IPTG诱导可溶性scFv的表达,经SDS-PAGE和Western印迹分析,scFv的分子量约为28kD.经亲和纯化后的scFv可与rhTNF-α结合,并可中和由rhTNF-α引起的L929细胞毒性.本文利用噬菌体抗体库筛选到了高亲和力的抗TNF-αscFv,为研制临床免疫治疗的新型抗体奠定了实验基础.     

特异结合人禽流感病毒H5N1的scFv分子性能鉴定

目的从人源化噬菌体抗体库（human single fold scFv libraries I＋J）中筛选到能高亲和性、特异结合人禽流感病毒H5N1的单链抗体,为建立H5N1快速筛查试剂和人源化治疗单抗奠定基础。方法以H5N1病毒的血凝素（hemagglutitin,HA）蛋白和核蛋白（nucleoprotein,NP）为目的蛋白,对上述单抗噬菌体文库以亲和性为原理进行筛选,经过3轮筛选富集后,随机挑选了96个噬菌体克隆扩增培养,ELISA法挑选能特异性、高亲和性结合目的蛋白的噬菌体克隆,并换用HB2151宿主菌对阳性单链抗体克隆进行可溶性表达,ELISA法鉴定可溶性单链抗体的结合活性,PCR扩增阳性克隆的轻、重链基因片段,并对阳性单链抗体分子测序和序列分析。结果经过3轮筛选,分别从96个噬菌体克隆中挑选到了两株能特异结合NP蛋白、3株能特异结合HA蛋白的单链抗体,PCR扩增都得到了长为300、302和935bp的轻链、重链和轻链-连接片段-重链的基因片段,测序结果分析发现上述5条单链抗体片段在轻链的47、49、50、51、53、54、56、96、97、98和99位的氨基酸组成不同,而特异结合NP蛋白的单链在重链区域氨基酸组成完全相同,而特异结合HA蛋白的单链在重链的44、47、85、86、87、88和89位氨基酸组成不同。结论从噬菌体抗体库中筛选到的特异结合HA和NP蛋白的单链抗体片段,可为进一步研发H5N1快速筛选试剂和人源性治疗抗体奠定基础,也可为鉴定HA和NP蛋白中的抗原决定簇提供结构信息。     

抗EGFRvIII噬菌体抗体库的构建和筛选

目的：应用噬菌体展示技术筛选针对表皮生长因子受体突变体Ш (epidermal growth factor receptor variant type Ⅲ, EGFRvIII)的单链抗体 (single chain Fv, scFv)。方法：利用原核表达纯化的人EGFRvIIIex蛋白和高表达EGFRvIIIex的小鼠成纤维细胞系NIH3T3免疫小鼠,扩增VH和VL片段并拼装成scFv 基因,连接至噬菌粒pCANTAB 5E,电击转化Hpd3cells,构建噬菌体单链抗体库,并进行3轮富集筛选。在第4轮筛选时,采用了降低抗原浓度的方法。然后将筛选得到的阳性克隆测序分析,转化E.coli HB2151,IPTG 诱导可溶性scFv 的表达。结果：构建了库容为7.9×107 的噬菌体单链抗体库。经过第4轮低浓度抗原筛选,得到了较高亲和力的克隆。取单个阳性克隆测序分析结果表明,该抗EGFRvIII scFv 基因序列长807 bp,编码268个氨基酸。IPTG诱导后表达的可溶性scFv 可分别与纯化的EGFRvIIIex抗原以及细胞表面的EGFRvIIIex结合。结论：利用噬菌体抗体库筛选得到了高亲和力的抗EGFRvIII scFv,为开发针对EGFRvIII的抗体药物提供了靶向载体分子。     

Development of recombinant single-chain variable fragment against hepatitis A virus and its use in quantification of hepatitis A antigen

Phage display technology has been utilized for identification of specific binding molecules to an antigenic target thereby enabling the rapid generation and selection of high affinity, fully human antibodies directed towards disease target appropriate for antibody therapy. In the present study, single chain Fv antibody fragment (scFv) to hepatitis A virus (HAV) was selected from phage displayed antibody library constructed from peripheral blood lymphocytes (PBLs) of a vaccinated donor. The variable heavy (V(H)) and light chains (V(L)) were amplified using cDNA as template, assembled into scFv using splicing by overlap extension PCR (SOE PCR) and cloned into phagemid vector as a fusion for display of scFv on bacteriophage. The phage displaying antibody fragments were subjected to three rounds of panning with HAV antigen on solid phase. High affinity antibodies reactive to hepatitis A virus were identified by phage ELISA and cloned into a bacterial expression vector pET20b. The scFv was purified by immobilized metal affinity chromatography (IMAC) on a nickel-nitrilotriacetic acid (NTA) agarose column and characterized. The binding activity and specificity of the scFv was established by its non-reactivity towards other human viral antigens as determined by ELISA and immunoblot analysis. The scFv was further used in the development of an in-house IC-ELISA format in combination with a commercially available mouse monoclonal antibody for the quantification of hepatitis A virus antigen in human vaccine preparations. The adjusted r2 values obtained by subjecting the values obtained by quantification of the NIBSC standards using the commercial and the in-house ELISA kits by regression analysis were 0.99 and 0.95. 39 vaccine samples were subjected to quantification using both the kits. Regressional statistical analysis through the origin of the samples indicated International Unit (IU) values of 0.0416x and 0.0419x, respectively for the commercial and in-house kit respectively.     

抗EGFRvⅢ噬菌体抗体库的构建和筛选

目的:应用噬菌体展示技术筛选针对表皮生长因子受体突变体Ш(epidermal growth factorreceptor variant typeⅢ,EGFRvIII)的单链抗体(single chain Fv,scFv)。方法:利用原核表达纯化的人EGFRvIIIex蛋白和高表达EGFRvIIIex的小鼠成纤维细胞系NIH3T3免疫小鼠,扩增VH和VL片段并拼装成scFv基因,连接至噬菌粒pCANTAB5E,电击转化Hpd3cells,构建噬菌体单链抗体库,并进行3轮富集筛选。在第4轮筛选时,采用了降低抗原浓度的方法。然后将筛选得到的阳性克隆测序分析,转化E.coliHB2151,IPTG诱导可溶性scFv的表达。结果:构建了库容为7.9×107的噬菌体单链抗体库。经过第4轮低浓度抗原筛选,得到了较高亲和力的克隆。取单个阳性克隆测序分析结果表明,该抗EGFRvIII scFv基因序列长807bp,编码268个氨基酸。IPTG诱导后表达的可溶性scFv可分别与纯化的EGFRvⅢex抗原以及细胞表面的EGFRvⅢex结合。结论:利用噬菌体抗体库筛选得到了高亲和力的抗EGFRvⅢ scFv,为开发针对EGFRvⅢ...     

Phage versus phagemid libraries for generation of human monoclonal antibodies

Non-immune (na?ve) phage antibody libraries have become an important source of antibodies for reagent, diagnostic, and therapeutic use. To date, reported na?ve libraries have been constructed in phagemid vectors as fusions to pIII, yielding primarily single copy (monovalent) display of antibody fragments. For this work, we subcloned the single chain Fv (scFv) gene repertoire from a na?ve phagemid antibody library into a true phage vector to create a multivalently displayed scFv phage library. Compared to monovalently displayed scFv, multivalent phage display resulted in improved efficiency of display as well as antibody selection. A greater number of antibodies were obtained and at earlier rounds of selection. Such increased efficiency allows the screening for binding antibodies after a single round of selection, greatly facilitating automation. Expression levels of antigen-binding scFv were also higher than from the phagemid library. In contrast, the affinities of scFv from the phage library were lower than from the phagemid library. This could be overcome by utilizing the scFv in a multivalent format, by affinity maturation, or by converting the library to monovalent display after the first round of selection.     

Cloning,expression, and identification of anti‐carbofuran single chain Fv gene

Phage display method was used to clone anti‐carbofuran (CBF) single chain Fv (scFv) gene. The heavy chain and light chain variable region genes were amplified by the polymerase chain reaction from the CBF‐specific hybridoma cell lines 5D3 and assembled as a scFv DNA fragment with linker peptide (Gly₄Ser)₃. The scFv DNA fragment was cloned into M13 phagemid vector pCANTAB5E and the anti‐CBF antibody libraries were then constructed. After one round of panning with CBF‐ovalbumin (CBF‐OVA) as a conjugate, antigen‐binding positive recombinant phage clones were successfully selected by enzyme‐linked immunosorbent assay (ELISA). The positive phages were used to infect Escherichia coli HB2151 cells and the expression of the soluble scFv antibodies was then induced by IPTG. The scFv antibody was about 31 kDa by SDS‐PAGE and showed HRP‐anti‐E‐tag antibody‐recognized activity by Western blotting. The indirect competitive ELISA (icELISA) showed that the recombinant scFv antibody could competitively combine with CBF, with the IC₅₀ value of 1.07 ng/mL. The cross reactivity studies showed that the anti‐CBF scFv antibody, similar to the parent monoclonal antibody, poses high specificity to CBF and has little reactivity to the analogs. Taken together, these findings suggest that the recombinant scFv antibody can be used for further developing immunoassay method for CBF. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009     

抗脐带间充质干细胞表面分子噬菌体ScFv抗体库的构建及初步鉴定

目的：利用噬菌体展示技术构建抗脐带间充质干细胞表面分子噬菌体ScFv抗体库。方法：收集P3代培养的UC-MSCs免疫BALB/c小鼠,提取其脾细胞总RNA,RT-PCR扩增全套VH和VL基因片段,将其先后克隆入噬菌粒pSEX81中,构建成完整的噬菌体ScFv抗体库。结果:构建的噬菌体ScFv抗体库的库容为2×107cfu,ScFv插入重组率为93％,BstN1酶切图谱呈不同多样性。ScFv抗体库经3轮初步筛选后插入重组率达100％,3个克隆出现了相同的酶切图谱,并且随着筛选次数的增加,输出/输入比明显提高,这说明抗体库得到了特异性富集。结论：成功地构建了抗脐带间充质干细胞表面分子噬菌体ScFv抗体库,这为将来筛选特异性抗体和进一步用于间充质干细胞表面特异性分子研究奠定了坚实的基础。